Sl No: Clinico-pathological parameters Total no of cases, (n = 220) % cases with elevated plasma VEGF-A levels Mean plasma VEGF-A level (pg/mL) P value
1. Mensus       0.0565
  Pre 63 (28.6%) 68.3% (43/63) 166.5  
  Post 157 (71.4%) 80.3% (126/157) 172.03  
2. Stage       <0.001
  I & II 73 (33.2%) 61.6% (45/73) 95.5  
  III & IV 128 (58.2%) 85.9% (110/128) 390.7  
3. Grade       0.0026
  Low grade 75 (34.1%) 62.7% (47/75) 97.7  
  High grade 126 (57.3%) 81.8% (103/126) 378.9  
4. Histopathology       <0.001
  Serous 134 (60.9%) 87.3% (117/134) 206  
  Mucinous 40 (18.2%) 50% (20/40) 96  
  Clear cell 6 (2.7%) 33.3% (2/6) 90.5  
  Endometrioid 7 (3.2%) 2.9% (2/7) 38  
  Poorly differentiated 33 (15%) 84.9% (28/33) 184.2  
5. CA-125 levels       <0.001
  0<35 23 (10.5%) 52.2% (12/23) 77.8  
  35-110 26 (11.8%) 53.9% (14/26) 164  
  110-1000 98 (44.6%) 78.6% (77/98) 367  
  >1000 73 (33.2%) 90.4% (66/73) 310  
6. Ascites presence       0.4689
  Yes 155 (70.5%) 75.5% (117/155) 350  
  No 65 (29.5%) 80% (52/65) 179  
7. Recurrence in <2 yrs       0.0248
  Yes 49 (22.3%) 78% (38/49) 242  
  No 118 (53.6%) 59.3% (70/118) 110  
Table 1: Correlation between clinico-pathological parameters and plasma VEGF-A levels in the case cohort.